Covered recipient · General Payments record
DREW ALAN PATE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry
General Payments · PY2020–2023
$539.80
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $194.86 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $57.85 | 2 |
| Teva Pharmaceuticals USA, Inc. | $39.97 | 2 |
| Neurocrine BioSciences, Inc. | $23.67 | 1 |
| Otsuka America Pharmaceutical, Inc. | $22.14 | 1 |
| Lundbeck LLC | $20.39 | 1 |
| BioXcel Therapeutics, Inc. | $16.62 | 1 |
| ITI, Inc. | $14.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $28.37 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022891897 | CMS |
| Alkermes, Inc. | $29.48 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022891899 | CMS |
| BioXcel Therapeutics, Inc. | $16.62 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057517267 | CMS |
| ITI, Inc. | $14.22 | 04/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040651361 | CMS |
| Lundbeck LLC | $20.39 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032311173 | CMS |
| Neurocrine Biosciences, Inc. | $23.67 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052122899 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.14 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014670419 | CMS |
| Teva Pharmaceuticals USA, Inc. | $22.01 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056880141 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.96 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056880159 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.